Other Species / Isoforms
  Yes (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
IKSKENKsPAIkyRP
Upstream
0 4
Treatment
  • nocodazole
  • thymidine
Yes (human) IKSKENKsPAIkyRP S11-p
Yes (mouse) IKSKENKsPAIkYTP S11-p
Yes (rat) IKSKENKSPAIKYTP S11
K15-ub
ENKsPAIkyRPENtP
0 2
Yes (human) ENKsPAIkyRPENtP K15-ub
Yes (mouse) ENKsPAIkYTPENLt K15-ub
Yes (rat) ENKSPAIKYTPENPT K15
Y16-p
NKsPAIkyRPENtPE
0 2
Yes (human) NKsPAIkyRPENtPE Y16-p
Yes (mouse) NKsPAIkYTPENLtE Y16
Yes (rat) NKSPAIKYTPENPTE Y16
T21-p
IkyRPENtPEPVsTs
0 7
Yes (human) IkyRPENtPEPVsTs T21-p
Yes (mouse) IkYTPENLtEPVsPS L21
Yes (rat) IKYTPENPTEPVNTS P21
P22
kyRPENtPEPVsTsV
0 2
Yes (human) kyRPENtPEPVsTsV P22
Yes (mouse) kYTPENLtEPVsPSA T22-p
Yes (rat) KYTPENPTEPVNTSA T22
S26-p
ENtPEPVsTsVsHyG
0 3
Yes (human) ENtPEPVsTsVsHyG S26-p
Yes (mouse) ENLtEPVsPSASHYG S26-p
Yes (rat) ENPTEPVNTSAGHyG N26
S28-p
tPEPVsTsVsHyGAE
0 1
Yes (human) tPEPVsTsVsHyGAE S28-p
Yes (mouse) LtEPVsPSASHYGVE S28
Yes (rat) PTEPVNTSAGHyGVE S28
S30-p
EPVsTsVsHyGAEPt
0 1
Yes (human) EPVsTsVsHyGAEPt S30-p
Yes (mouse) EPVsPSASHYGVEHA S30
Yes (rat) EPVNTSAGHyGVEHA G30
Y32-p
VsTsVsHyGAEPttV
1 96
Yes (human) VsTsVsHyGAEPttV Y32-p
Yes (mouse) VsPSASHYGVEHATV Y32
Yes (rat) VNTSAGHyGVEHATA Y32-p
T37-p
sHyGAEPttVsPCPS
0 1
Yes (human) sHyGAEPttVsPCPS T37-p
Yes (mouse) SHYGVEHATVAPTSs A37
Yes (rat) GHyGVEHATAATTSS A37
T38-p
HyGAEPttVsPCPSs
0 1
Yes (human) HyGAEPttVsPCPSs T38-p
Yes (mouse) HYGVEHATVAPTSsT T38
Yes (rat) HyGVEHATAATTSST T38
S40-p
GAEPttVsPCPSssA
Upstream
0 7
Treatment
  • nocodazole
  • thymidine
Yes (human) GAEPttVsPCPSssA S40-p
Yes (mouse) GVEHATVAPTSsTKG A40
Yes (rat) GVEHATAATTSSTKG A40
S45-p
tVsPCPSssAKGTAV
0 1
Yes (human) tVsPCPSssAKGTAV S45-p
Yes (mouse) HATVAPTSsTKGASV S43
Yes (rat) HATAATTSSTKGASA S43
S46-p
VsPCPSssAKGTAVN
0 2
Yes (human) VsPCPSssAKGTAVN S46-p
Yes (mouse) ATVAPTSsTKGASVN S44-p
Yes (rat) ATAATTSSTKGASAN S44
T69
FGGSSGVTPFGGASS
0 1
Yes (human) FGGSSGVTPFGGASS T69
Yes (mouse) FGGSSGVtPFGGASs T67-p
Yes (rat) FGGSSGVTPFGGASS T67
S76
TPFGGASSSFSVVPS
0 1
Yes (human) TPFGGASSSFSVVPS S76
Yes (mouse) tPFGGASssFSVVSS S74-p
Yes (rat) TPFGGASSSFSVVPS S74
S77
PFGGASSSFSVVPSS
0 1
Yes (human) PFGGASSSFSVVPSS S77
Yes (mouse) PFGGASssFSVVSSS S75-p
Yes (rat) PFGGASSSFSVVPSS S75
Y100-p
VTIFVALyDYEARTT
0 11
Yes (human) VTIFVALyDYEARTT Y100-p
Yes (mouse) VTIFVALyDYEARTT Y98-p
Yes (rat) VTIFVALYDYEARTT Y98
S111-p
ARTTEDLsFKKGERF
Upstream
0 3
Treatment
  • nocodazole
  • thymidine
Yes (human) ARTTEDLsFKKGERF S111-p
Yes (mouse) ARTTEDLSFKKGERF S109
Yes (rat) ARTTEDLSFKKGERF S109
K138-ub
ARSIATGkNGyIPsN
0 1
Yes (human) ARSIATGkNGyIPsN K138-ub
Yes (mouse) ARSIATGKSGYIPSN K136
Yes (rat) ARSIATGKNGYIPSN K136
Y141-p
IATGkNGyIPsNyVA
Upstream
0 12
Treatment
  • imatinib
Yes (human) IATGkNGyIPsNyVA Y141-p
Yes (mouse) IATGKSGYIPSNYVV Y139
Yes (rat) IATGKNGYIPSNYVA Y139
S144-p
GkNGyIPsNyVAPAD
0 1
Yes (human) GkNGyIPsNyVAPAD S144-p
Yes (mouse) GKSGYIPSNYVVPAD S142
Yes (rat) GKNGYIPSNYVAPAD S142
Y146-p
NGyIPsNyVAPADSI
Upstream
0 4
Treatment
  • imatinib
Yes (human) NGyIPsNyVAPADSI Y146-p
Yes (mouse) SGYIPSNYVVPADSI Y144
Yes (rat) NGYIPSNYVAPADSI Y144
Y159-p
SIQAEEWyFGKMGRK
0 11
Yes (human) SIQAEEWyFGKMGRK Y159-p
Yes (mouse) SIQAEEWyFGKMGRK Y157-p
Yes (rat) SIQAEEWYFGKMGRK Y157
K191-ub
VRESETTkGAysLSI
0 8
Yes (human) VRESETTkGAysLSI K191-ub
Yes (mouse) VRESETTkGAysLSI K189-ub
Yes (rat) VRESETTKGAysLSI K189
Y194-p
SETTkGAysLSIRDW
Upstream
0 370
Treatment
  • nocodazole
Yes (human) SETTkGAysLSIRDW Y194-p
Yes (mouse) SETTkGAysLSIRDW Y192-p
Yes (rat) SETTKGAysLSIRDW Y192-p
S195-p
ETTkGAysLSIRDWD
0 12
Yes (human) ETTkGAysLSIRDWD S195-p
Yes (mouse) ETTkGAysLSIRDWD S193-p
Yes (rat) ETTKGAysLSIRDWD S193-p
Y222-p
RKLDNGGyyITTRAQ
Upstream
0 1816
Regulatory protein:
  • FGFR1 (human)
Treatment
  • erlotinib
Yes (human) RKLDNGGyyITTRAQ Y222-p
Yes (mouse) RKLDNGGyyITTRAQ Y220-p
Yes (rat) RKLDNGGyyITTRAQ Y220-p
Y223-p
KLDNGGyyITTRAQF
0 675
Yes (human) KLDNGGyyITTRAQF Y223-p
Yes (mouse) KLDNGGyyITTRAQF Y221-p
Yes (rat) KLDNGGyyITTRAQF Y221-p
K235
AQFDTLQKLVkHYTE
0 1
Yes (human) AQFDTLQKLVkHYTE K235
Yes (mouse) AQFDTLQKLVKHYTE K233
Yes (rat) AQFDTLQkLVKHYTE K233-ac
K235-ub
AQFDTLQkLVkHYTE
0 4
Yes (human) AQFDTLQkLVkHYTE K235-ub
Yes (mouse) AQFDTLQkLVKHYTE K233-ub
Yes (rat) AQFDTLQKLVKHYTE K233
K238-ub
DTLQkLVkHYTEHAD
0 1
Yes (human) DTLQkLVkHYTEHAD K238-ub
Yes (mouse) DTLQkLVKHYTEHAD K236
Yes (rat) DTLQkLVKHYTEHAD K236
K250-ub
HADGLCHkLTTVCPT
0 1
Yes (human) HADGLCHkLTTVCPT K250-ub
Yes (mouse) HADGLCHKLTTVCPt K248
Yes (rat) HADGLCHKLTTVCPT K248
T257
kLTTVCPTVkPQtQG
0 1
Yes (human) kLTTVCPTVkPQtQG T257
Yes (mouse) KLTTVCPtVKPQtQG T255-p
Yes (rat) KLTTVCPTVKPQTQG T255
K259-ub
TTVCPTVkPQtQGLA
0 2
Yes (human) TTVCPTVkPQtQGLA K259-ub
Yes (mouse) TTVCPtVKPQtQGLA K257
Yes (rat) TTVCPTVKPQTQGLA K257
T262-p
CPTVkPQtQGLAkDA
0 2
Yes (human) CPTVkPQtQGLAkDA T262-p
Yes (mouse) CPtVKPQtQGLAKDA T260-p
Yes (rat) CPTVKPQTQGLAKDA T260
K267-ub
PQtQGLAkDAWEIPR
0 1
Yes (human) PQtQGLAkDAWEIPR K267-ub
Yes (mouse) PQtQGLAKDAWEIPR K265
Yes (rat) PQTQGLAKDAWEIPR K265
K308
KVAIKTLKPGTMMPE
0 1
Yes (human) KVAIKTLKPGTMMPE K308
Yes (mouse) KVAIKTLkPGTMMPE K306-ub
Yes (rat) KVAIKTLKPGTMMPE K306
K325-ub
LQEAQIMkKLRHDKL
0 1
Yes (human) LQEAQIMkKLRHDKL K325-ub
Yes (mouse) LQEAQIMKkLRHDKL K323
Yes (rat) LQEAQIMKKLRHDKL K323
K326
QEAQIMkKLRHDKLV
0 1
Yes (human) QEAQIMkKLRHDKLV K326
Yes (mouse) QEAQIMKkLRHDKLV K324-ub
Yes (rat) QEAQIMKKLRHDKLV K324
Y336-p
HDKLVPLyAVVSEEP
0 8
Yes (human) HDKLVPLyAVVSEEP Y336-p
Yes (mouse) HDKLVPLYAVVSEEP Y334
Yes (rat) HDKLVPLYAVVSEEP Y334
Y345-p
VVSEEPIyIVTEFMS
0 36
Yes (human) VVSEEPIyIVTEFMS Y345-p
Yes (mouse) VVSEEPIyIVTEFMS Y343-p
Yes (rat) VVSEEPIyIVTEFMS Y343-p
K361-ub
GSLLDFLkEGDGKYL
0 1
Yes (human) GSLLDFLkEGDGKYL K361-ub
Yes (mouse) GSLLDFLKEGDGKYL K359
Yes (rat) GSLLDFLKEGDGKYL K359
Y426-p
RLIEDNEytARQGAK
Upstream
7 3123
Yes (human)
Y426-p
Yes (mouse)
Y424-p
Yes (rat)
Y424-p
Putative in vivo kinases:
  • AXL (human)
Regulatory protein:
  • TLR4 (human)
Treatment
  • anti-CD3
  • cell_detachment
  • dasatinib
  • FGF2
  • HGF
  • LPA
  • LPS
  • PP2
  • siRNA
  • SU6656
  • U0126
Yes (human) RLIEDNEytARQGAK Y426-p
Yes (mouse) RLIEDNEytARQGAK Y424-p
Yes (rat) RLIEDNEyTARQGAK Y424-p
T427-p
LIEDNEytARQGAKF
0 24
Yes (human) LIEDNEytARQGAKF T427-p
Yes (mouse) LIEDNEytARQGAKF T425-p
Yes (rat) LIEDNEyTARQGAKF T425
Y446-p
TAPEAALyGRFTIKS
Upstream
1 544
Treatment
  • serum_starvation
  • U0126
Yes (human) TAPEAALyGRFTIKS Y446-p
Yes (mouse) TAPEAALyGRFTIKS Y444-p
Yes (rat) TAPEAALyGRFTIKS Y444-p
K468-ub
LQTELVTkGRVPYPG
0 1
Yes (human) LQTELVTkGRVPYPG K468-ub
Yes (mouse) LQTELVTKGRVPYPG K466
Yes (rat) LQTELVTKGRVPYPG K466
K510-ub
ELMNLCWkKDPDERP
0 1
Yes (human) ELMNLCWkKDPDERP K510-ub
Yes (mouse) ELMNLCWKKDPDERP K508
Yes (rat) ELMNLCWKKDPDERP K508
T533-p
LEDYFTAtEPQyQPG
0 3
Yes (human) LEDYFTAtEPQyQPG T533-p
Yes (mouse) LEDYFTATEPQyQPG T531
Yes (rat) LEDYFTATEPQyQPG T531
Y537-p
FTAtEPQyQPGENL_
Upstream
Downstream
4 1267
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • CSK (human)
Treatment
  • serum_starvation
  • SII_angiotensin_2
Yes (human) FTAtEPQyQPGENL_ Y537-p
Yes (mouse) FTATEPQyQPGENL_ Y535-p
Yes (rat) FTATEPQyQPGENL_ Y535-p